257 related articles for article (PubMed ID: 12020813)
1. Targeted adenoviral vectors.
Barnett BG; Crews CJ; Douglas JT
Biochim Biophys Acta; 2002 May; 1575(1-3):1-14. PubMed ID: 12020813
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vectors for gene therapy.
Douglas JT
Mol Biotechnol; 2007 May; 36(1):71-80. PubMed ID: 17827541
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.
Kim M; Zinn KR; Barnett BG; Sumerel LA; Krasnykh V; Curiel DT; Douglas JT
Eur J Cancer; 2002 Sep; 38(14):1917-26. PubMed ID: 12204675
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
5. New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.
Reynolds PN; Curiel DT
Kidney Int; 2002 Jan; 61(1 Suppl):S24-31. PubMed ID: 11841608
[TBL] [Abstract][Full Text] [Related]
6. Cancer-targeting gene therapy using tropism-modified adenovirus.
Tanaka T; Kuroki M; Hamada H; Kato K; Kinugasa T; Shibaguchi H; Zhao J; Kuroki M
Anticancer Res; 2007; 27(6A):3679-84. PubMed ID: 17970028
[TBL] [Abstract][Full Text] [Related]
7. Targeted adenovirus vectors.
Mizuguchi H; Hayakawa T
Hum Gene Ther; 2004 Nov; 15(11):1034-44. PubMed ID: 15610604
[TBL] [Abstract][Full Text] [Related]
8. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35].
Sakurai F
Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294
[TBL] [Abstract][Full Text] [Related]
9. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
[TBL] [Abstract][Full Text] [Related]
10. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors.
Douglas JT; Curiel DT
Neuromuscul Disord; 1997 Jul; 7(5):284-98. PubMed ID: 9267842
[TBL] [Abstract][Full Text] [Related]
11. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
Krasnykh V; Dmitriev I; Navarro JG; Belousova N; Kashentseva E; Xiang J; Douglas JT; Curiel DT
Cancer Res; 2000 Dec; 60(24):6784-7. PubMed ID: 11156365
[TBL] [Abstract][Full Text] [Related]
12. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.
Haisma HJ; Pinedo HM; Rijswijk A; der Meulen-Muileman I; Sosnowski BA; Ying W; Beusechem VW; Tillman BW; Gerritsen WR; Curiel DT
Gene Ther; 1999 Aug; 6(8):1469-74. PubMed ID: 10467371
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
[TBL] [Abstract][Full Text] [Related]
15. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer to brain and spinal cord using recombinant adenoviral vectors.
Alisky JM; Davidson BL
Methods Mol Biol; 2004; 246():91-120. PubMed ID: 14970587
[TBL] [Abstract][Full Text] [Related]
17. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
18. New serotypes of adenoviral vectors.
Stone D; Lieber A
Curr Opin Mol Ther; 2006 Oct; 8(5):423-31. PubMed ID: 17078384
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
Sakurai F; Kawabata K; Mizuguchi H
Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607
[TBL] [Abstract][Full Text] [Related]
20. Transductional targeting of adenovirus vectors for gene therapy.
Glasgow JN; Everts M; Curiel DT
Cancer Gene Ther; 2006 Sep; 13(9):830-44. PubMed ID: 16439993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
